A. Wollenberg, “Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial”, J of Skin, vol. 6, no. 6, p. s75, Nov. 2022.